80 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and terms and conditions included in the contracts with the service providers. In addition, in certain circumstances, the determination of the nature … . The Company may invest its excess cash in mutual funds that are classified based on the nature of their underlying securities and their availability for use
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
current and future preclinical and clinical development projects. Due to the inherently unpredictable nature of preclinical and clinical development … is, by its nature, uncertain given that estimates depend on events over which we may not have control. If market and other conditions change from those
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
that are classified based on the nature of their underlying securities and their availability for use in current operations. The Company’s marketable
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
in accordance with the volume and nature of their services.
FOR
AGAINST
ABSTAIN
The undersigned hereby acknowledges receipt of the Notice of the Annual
6-K
EX-99.1
xc9 horyzi34pvx
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
3b8v1w0sqac9u
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
31s2f25onn8fi7ul8nvc
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
iozybqyaf8vvfkujo z6
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
u3blwsm8woipdv
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
cmrwg6ll76mms umcpxd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
2p96m4
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
6ve53fio47 onda6xa54
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
ma81k40b7k
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
gorkfjgm6mq8ugso
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.2
2wur3 62i8fothgo
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
yyqps12b weranak
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
twuemqcpkq
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.2
ycxo1re djmt
27 May 22
Condensed Consolidated Financial Statements
4:39pm